Submitted:
12 May 2025
Posted:
13 May 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Cells, Plasmids and Reagents
2.2. (. RT)-PCR Detection for Common Duck Viruses
2.3. Virus Isolation and Viral Amplification
2.4. Phylogenetic Analysis
2.5. Construction of DAdV-3 Infectious Clone
2.6. Virus Rescue
2.7. Indirect Immunofluorescence Assay (IFA)
2.8. Viral Growth Kinetics
2.9. Virus Titration
2.10. Duck Experiments
2.11. The qPCR Assay
2.12. Antibody Detection
2.13. Ethics Statement and Statistical Analysis
3. Results
3.1. Virus Isolation and Identification
3.2. Phylogenetic Analysis
3.3. Generation of DAdV-3 Infectious Clone
3.4. Virus Rescue
3.5. Growth Curves of rSD2019 and wtSD2019 in LMH Cells
3.6. Pathogenicity of rSD2019 and wtSD2019 in Muscovy Ducks
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
References
- Greber, U.F., Adenoviruses - Infection, pathogenesis and therapy. FEBS Lett, 2020. 594(12): p. 1818-1827.
- Tan, Y., et al., Isolation, characterization, evaluation of pathogenicity, and immunomodulation through interferon production of duck adenovirus type-3 (DAdV-3). Poult Sci, 2024. 103(3): p. 103411. [CrossRef]
- Huang, Y., et al., Isolation and partial genetic characterization of a new duck adenovirus in China. Vet Microbiol, 2020. 247: p. 108775. [CrossRef]
- Zhang, X., et al., Molecular characterization, phylogeny analysis and pathogenicity of a Muscovy duck adenovirus strain isolated in China in 2014. Virology, 2016. 493: p. 12-21. [CrossRef]
- Shi, S., et al., Isolation and characterization of duck adenovirus 3 circulating in China. Arch Virol, 2019. 164(3): p. 847-851. [CrossRef]
- Shi, X., et al., Isolation and pathogenic characterization of duck adenovirus 3 mutant circulating in China. Poult Sci, 2022. 101(1): p. 101564. [CrossRef]
- Yin, L., et al., Epidemiological investigation of duck adenovirus 3 in southern China, during 2018-2020. Avian Pathol, 2022. 51(2): p. 171-180. [CrossRef]
- Wan, C., et al., Development of a TaqMan-based real-time PCR for detecting duck adenovirus 3. J Virol Methods, 2018. 261: p. 86-90. [CrossRef]
- François, A., et al., Construction of avian adenovirus CELO recombinants in cosmids. J Virol, 2001. 75(11): p. 5288-301. [CrossRef]
- Wen, Y., et al., Construction and immune evaluation of the recombinant duck adenovirus type 3 delivering capsid protein VP1 of the type 1 duck hepatitis virus. Poult Sci, 2023. 102(12): p. 103117. [CrossRef]
- Pei, Y., et al., Fowl Adenovirus 4 (FAdV-4)-Based Infectious Clone for Vaccine Vector Development and Viral Gene Function Studies. Viruses, 2018. 10(2). [CrossRef]
- Pan, Q., et al., Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4. Front Microbiol, 2021. 12: p. 780978. [CrossRef]
- Tang, Z., et al., Generation of an artificially attenuated fowl adenovirus 4 viral vector using the reverse genetics system based on full-length infectious clone. Vet Res, 2025. 56(1): p. 62. [CrossRef]
- Johnson, M.A., et al., A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus. Vaccine, 2003. 21(21-22): p. 2730-6. [CrossRef]
- Pei, Y., et al., Rapid generation of fowl adenovirus 9 vectors. J Virol Methods, 2015. 223: p. 75-81. [CrossRef]
- Li, X., et al., Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus. PLoS One, 2012. 7(12): p. e53026. [CrossRef]
- Zhang, X., et al., Molecular characterization, phylogeny analysis and pathogenicity of a Muscovy duck adenovirus strain isolated in China in 2014. Virology, 2016. 493: p. 12-21. [CrossRef]
- Yin, L., et al., Epidemiological investigation of duck adenovirus 3 in southern China, during 2018-2020. Avian Pathol, 2022. 51(2): p. 171-180. [CrossRef]
- Shi, S., et al., Isolation and characterization of duck adenovirus 3 circulating in China. Arch Virol, 2019. 164(3): p. 847-851. [CrossRef]
- Shi, X., et al., Isolation and pathogenic characterization of duck adenovirus 3 mutant circulating in China. Poult Sci, 2022. 101(1): p. 101564. [CrossRef]
- Wen, Y., et al., Construction and immune evaluation of the recombinant duck adenovirus type 3 delivering capsid protein VP1 of the type 1 duck hepatitis virus. Poult Sci, 2023. 102(12): p. 103117. [CrossRef]
- Tan, Y., et al., Isolation, characterization, evaluation of pathogenicity, and immunomodulation through interferon production of duck adenovirus type-3 (DAdV-3). Poult Sci, 2024. 103(3): p. 103411. [CrossRef]





| Primer name | Sequence(5’→3’) | Size |
| DAdV-3-F | GTACCGCCTTCGAGAACACA | 1014 bp |
| DAdV-3-1014R | GCTGTCTGATTCTGGTGATC | |
| DPV-REP-F | CAAACGGGGAGGGCAAAATAAGA | 600 bp |
| DPV-REP-600R | GTGGTCGCAGGTCCGTAGAGC | |
| GPV-F | CCAAGCTACAACAACCACATCTAC | 375 bp |
| GPV-375R | CTGCGGCAGGGCATAGACATCCGAC | |
| DEV-F | GGACAGCGTACCACAGATAA | 520 bp |
| DEV-520R | ACAAATCCCAAGCGTAG | |
| DuCV-F | CGGCGCTTGTACTCCGTACTC | 619 bp |
| DuCV-619R | CCCGCGTGGTTTGTAATACTTG | |
| FAdV-4-F | CAACTACATCGGGTTCAGGGATAACTTC | 667 bp |
| FAdV-4-667R | CCAGTTTCTGTGGTGGTTGAAGGGGTT | |
| AIV-F | TTCTAACCGAGGTCGAAAC | 229 bp |
| AIV-229R | AAGCGTCTACGCTGCAGTCC | |
| DTMUV-F | CATAGGCTGGAATCTGGGAAC | 300 bp |
| DTMUV-300R | TCTGGATTCTGTCGTCACGTC | |
| DHAV-1-F | CAGTTTACCGCCCCACTCTAT | 699 bp |
| DHAV-1-699R | TGGCTTCCACCTCCTCTTCAT | |
| DHAV-3-F | GAAATCTGCACTCAATGGAGAG | 286 bp |
| DHAV-3-286R | CCCAGGAAATGATTGGTCAG | |
| NDV-F | TGTAGTAACGGGAGACAAAGCAG | 350 bp |
| NDV-350R | GAATAAATACCAGGAGACATAGGGA | |
| NDRV-F | GCATGAACATGCCAGTTGAG | 300 bp |
| NDRV-300R | AAGCCATAACGATGGCAGTC | |
| DAdV-3-PacI-F | CAATTTACCGATGGTATATATATGATGATGTTAATTAATTTCCATAGGCTCCGC | 2000 bp |
| DAdV-3-PacI-2000R | CAATTTACCGATGGTATATATATGATGATGTTAATTAAACGCGCCCTGTAGCGG | |
| pDAdV-3 Kana F | AGCGTGGCGCTTTCTCATAG | 1800 bp |
| pDAdV-3 Kana R | CTTTCGCTTTCTTCCCTTCC |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).